Related Experiment Videos
Indoleamine stores in maturing mouse brain reexposed to citalopram following extended uptake inhibition
Abstract:
1. Mice of various ages between birth and adulthood were injected daily for 5 days with the serotonin specific uptake inhibitor citalopram (LU 10-171). 2 days later they were reinjected with citalopram 2. 2 hr, 1 day and 3 days following the last injection animals were killed and their brains assayed for 5-hydroxytryptamine (5-HT) and 5-hydroxyindole acetic acid (5-HIAA). 3. Brains were found to still respond to citalopram's acute action despite the fact younger brains had undergone long term alteration of 5-HIAA stores. 4. The possibility that indoleamines are subject to different regulatory mechanisms in young brain is discussed.
Insights
Young and adult mice treated with citalopram showed altered 5-hydroxyindole acetic acid (5-HIAA) levels. Despite these changes, young brains still responded to citalopram
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Serotonin (5-hydroxytryptamine, 5-HT) plays a crucial role in brain development and function.
- Selective serotonin reuptake inhibitors (SSRIs) like citalopram are widely used to treat various neurological and psychiatric conditions.
- Understanding the long-term effects of SSRIs on developing brains is essential for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate the impact of chronic citalopram administration on serotonin metabolism in mice of different ages.
- To determine if developmental stage influences the brain's response to long-term SSRI treatment.
- To explore potential age-dependent differences in the regulation of indoleamine pathways.
Main Methods:
- Mice across various age groups (birth to adulthood) received daily citalopram injections for five days.
- Following a two-day washout period, animals were re-exposed to citalopram.
- Brain tissues were analyzed for 5-hydroxytryptamine (5-HT) and 5-hydroxyindole acetic acid (5-HIAA) levels at multiple time points post-injection.
Main Results:
- Chronic citalopram treatment led to long-term alterations in 5-hydroxyindole acetic acid (5-HIAA) stores, particularly in younger brains.
- Despite these alterations, the brains of young mice retained the capacity to respond to the acute effects of citalopram.
- No significant age-related differences were observed in the acute response to citalopram, even with prior chronic exposure.
Conclusions:
- Developing brains exhibit distinct long-term adaptations in indoleamine metabolism in response to citalopram.
- The acute regulatory mechanisms of serotonin appear to remain functional in young brains, irrespective of prior chronic SSRI exposure.
- These findings suggest that indoleamine pathways may be subject to differential regulatory mechanisms during early brain development.